Maturitas
Volume 41, Issue 3 , Pages 177-185 , 25 March 2002

Lipoproteins and BMI: a comparison between women during transition to menopause and regularly menstruating healthy women

  • Gerd Hall

      Affiliations

    • Department of Obstetrics and Gynaecology, Huddinge University Hospital, SE-14186 Huddinge, Sweden
    • Corresponding Author InformationCorresponding author
    • ,
  • Aila Collins

      Affiliations

    • Department of Clinical Neuroscience, Psychiatry and Psychology Section, Karolinska Hospital, SE-171 76 Stockholm, Sweden
    • ,
  • György Csemiczky

      Affiliations

    • Department of Obstetrics and Gynaecology, Karolinska Hospital, SE-171 76 Stockholm, Sweden
    • ,
  • Britt-Marie Landgren

      Affiliations

    • Department of Obstetrics and Gynaecology, Huddinge University Hospital, SE-14186 Huddinge, Sweden

Received 2 January 2001 ,Revised 30 May 2001 ,Accepted 11 June 2001.

References 

  1. Trémolliéres FA, Pouilles J-M, Cauneille C, Ribot C. Coronary heart disease risk factors and menopause: a study in 1684 French women. Atheriosclerosis. 1999;142:415–423
  2. Mosinger BJ. Human low-density lipoproteins: oxidative modification and its relation to age, gender, menopausal status and cholesterol concentrations. Eur. J. Clin. Chem. Clin. Biochem. 1997;35:207–214
  3. Lindquisl O, Bengtsson C, Lapidus L. Relationships between the menopause and risk factors for ischaemic heart disease. Acta Obstet. Gynecol. Scand. Suppl. 1985;130:43–47
  4. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR. Menopause and risk factors for coronary heart disease. New Engl. J. Med. 1989;10:641–646
  5. Schaefer EJ, Lamon-Fava S, Cohn SD, Schaefer MM, Ordovas JM, Castelli WP, et al. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. J. Lipid Res. 1994;35:779–792
  6. Razay G, Heaton KW, Bolton CH. Coronary heart disease risk factors in relation to the menopause. Quart J Med New Ser 1992;85:307–8; 889–96.
  7. Poehlman ET, Toth MF, Ades PA, Rosen CJ. Menopause-associated changes in plasma lipids, insulin like growth factor I and blood pressure: a longitudinal study. Eur. J. Clin. Invest. 1997;4:322–326
  8. Brochier ML, Arwidson P. Coronary heart disease risk factors in women. Eur. Heart J. 1998;19(Suppl. A):A45–A52
  9. Bush TL, Fried LP, Barrett-Connor E. Cholesterol, lipoproteins and coronary heart disease in women. Clin. Chem. 1988;34B:B60–B70
  10. Kannel WB. Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study. Am. Heart J. 1987;114:413–419
  11. Barrett-Connor E, Grady D. Hormone replacement therapy, heart disease and other considerations. Ann. Rev. Public Health. 1998;19:55–72
  12. Grady D, Rubin SM, Petitti DB, et al.  Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann. Intern. Med. 1992;117:1016–10137
  13. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev. Med. 1991;20:47–63
  14. Mattews KA, Kuller LH, Wing RR, Meilahn EN, Plantinga P. Prior to use of estrogen replacement therapy, are users healthier than nonusers. Am. J. Epidemiol. 1996;143:971–978
  15. Lindquist O. Intravidual changes of blood pressure, serum lipids and body weight in relation to menstrual status: results from a prospective population study of women in Goteborg. Sweden. Prev. Med. 1982;11:162–172
  16. Anderson KM, Wilson PWF, Garrison RJ, Castelli WP. Longitudinal and secular trends in lipoprotein cholesterol measurements in a general population sample. The Framingham Offspring Study. Atherosclerosis. 1987;6B:59–66
  17. Van Beresteijn ECH, Korevaar JC, Huijbregts PCW, Schouten EG, Burema JM, Kok FJ. Perimenopausal increase in serum cholesterol: a 10-year longitudinal study. Am. J. Epidemiol. 1993;137:383–392
  18. Matthews KA, Wing RR, Kuller LH, Meilahn EN, Plantinga P. Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women. Arch. Intern. Med. 1994;154:2349–2355
  19. Fukami K, Koike K, Hirota K, Yoshikawa H, Miyake A. Perimenopausal changes in scrum lipids and lipoproteins: a 7-year longitudinal study. Maturitas. 1995;22:193–197
  20. Collins A, Landgren B-M. Psychosocial factors associated with the use of hormonal replacement therapy in a longitudinal follow-up of Swedish women. Maturitas. 1999;28:1–9
  21. Do K-A, Green A, Guthrie JR, Dudley EC, Burger HG, Dennerstein L. Longitudinal study of risk factors for coronary heart disease across the menopausal transition. Am. J. Epidemiol. 2000;151:584–593
  22. Cooper GR, De Keersgleter W, Ezurra EJ, Rosseneu M, Shephered J, d'Arcangues C. Method Manual for Lipid, Lipoprotein and Apolipoprotein Determinations, 1989.
  23. ACS, Apotekel AB. 0006 30.
  24. Moorhead T, Hannaford P, Warskyj M. Prevalence and characteristics associated with use of hormone replacement therapy in Britain. Br. J. Obstet. Gynaecol. 1997;104:290–297
  25. Jensen J, Nilas L, Christiansen C. Influence of menopause on serum lipids and lipoproteins. Maturitas. 1990;12:321–331
  26. Stevenson JC, Crook D, Godsland IF. Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atheriosclerosis. 1993;98:83–93

PII: S0378-5122(01)00258-4

Maturitas
Volume 41, Issue 3 , Pages 177-185 , 25 March 2002

Article Tools

* Image Usage & Resolution